We read with interest the article by Messer et al.1 reporting a significant increase in time in range (TIR, +9%, P < 0.001) in 191 children and adolescents using a closed-loop control (CLC) system (Tandem t:slim X2 insulin pump with Control-IQ technology, San Diego, CA). This result is noteworthy given the difficulties in achieving good glycemic control, especially in children.2,3 In addition to technology, we believe that education, especially when designed for sharing between pediatric centers, can maximize the benefits of new diabetes technology. To this end, in 2020 and at the same time as CLC with the Control-IQ system was introduced in Italy, we organized a virtual educational camp (vEC) for children and adolescents with type 1 diabetes. The aims, structure, and 3- and 6-month outcomes of the vEC are detailed elsewhere.4,5 In this study, we present the glycemic metrics 9 months after the vEC. Nineteen Italian pediatric diabetes centers participated in this IRB-approved prospective multicenter clinical study.4,5 Children (6–17 years) who had already used the Basal-IQ system for at least 3 months with the carbohydrate counting system and were available to test Control-IQ and share their data on data-syncing software were enrolled and actively participated in the vEC.4 Each patient was then followed up by their own center every 3 months. If needed, teleconsultation and televisits were offered. The main study outcomes are as shown in Table 1. The 43 participants were aged 7–16 years (median 12, interquartile range [IQR] 9–13), of whom 53.5% were female. The duration of diabetes ranged from 2 to 13 years (median 6; IQR 4–9). The median body mass index z-score was −0.2 (IQR −0.6 to 0.2), and 19 (45%) participants were prepubertal according to Tanner's classification.

Comment on “Real-World Use of a New Hybrid Closed Loop Improves Glycemic Control in Youth with Type 1 Diabetes” by Messer et al

Iafusco, Dario
Conceptualization
;
2022

Abstract

We read with interest the article by Messer et al.1 reporting a significant increase in time in range (TIR, +9%, P < 0.001) in 191 children and adolescents using a closed-loop control (CLC) system (Tandem t:slim X2 insulin pump with Control-IQ technology, San Diego, CA). This result is noteworthy given the difficulties in achieving good glycemic control, especially in children.2,3 In addition to technology, we believe that education, especially when designed for sharing between pediatric centers, can maximize the benefits of new diabetes technology. To this end, in 2020 and at the same time as CLC with the Control-IQ system was introduced in Italy, we organized a virtual educational camp (vEC) for children and adolescents with type 1 diabetes. The aims, structure, and 3- and 6-month outcomes of the vEC are detailed elsewhere.4,5 In this study, we present the glycemic metrics 9 months after the vEC. Nineteen Italian pediatric diabetes centers participated in this IRB-approved prospective multicenter clinical study.4,5 Children (6–17 years) who had already used the Basal-IQ system for at least 3 months with the carbohydrate counting system and were available to test Control-IQ and share their data on data-syncing software were enrolled and actively participated in the vEC.4 Each patient was then followed up by their own center every 3 months. If needed, teleconsultation and televisits were offered. The main study outcomes are as shown in Table 1. The 43 participants were aged 7–16 years (median 12, interquartile range [IQR] 9–13), of whom 53.5% were female. The duration of diabetes ranged from 2 to 13 years (median 6; IQR 4–9). The median body mass index z-score was −0.2 (IQR −0.6 to 0.2), and 19 (45%) participants were prepubertal according to Tanner's classification.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11591/485549
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 1
social impact